{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:48:15Z","timestamp":1788691695991,"version":"build-2803163510"},"reference-count":44,"publisher":"American Veterinary Medical Association (AVMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p>Rabies is the deadliest viral infection known, with no reliable treatment, and although it is entirely preventable, rabies continues to kill more than 60,000 people every year, mostly children in countries where dog rabies is endemic. America is only 1 generation away from the time when rabies killed more than 10,000 animals and 50 Americans every year, but 3 to 5 Americans continue to die annually from rabies. Distressingly, &gt; 50,000 Americans undergo rabies prevention therapy every year after exposure to potentially rabid animals. While enormous progress has been made, more must be done to defeat this ancient but persistent, fatal zoonosis.<\/jats:p>\n<jats:p>In the US, lack of public awareness and ambivalence are the greatest dangers imposed by rabies, resulting in unnecessary exposures, anxiety, and risk. Veterinarians have a special role in informing and reassuring the public about prevention and protection from rabies. This summary of current facts and future advances about rabies will assist veterinarians in informing their clients about the disease.<\/jats:p>","DOI":"10.2460\/javma.22.09.0420","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T16:52:17Z","timestamp":1670431937000},"page":"592-596","source":"Crossref","is-referenced-by-count":11,"title":["Rabies: who should care?"],"prefix":"10.2460","volume":"261","author":[{"given":"Henry J.","family":"Baker","sequence":"first","affiliation":[{"name":"Scott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, AL"},{"name":"Department of Pathobiology, College of Veterinary Medicine, Auburn University, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Martin","sequence":"additional","affiliation":[{"name":"Scott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, AL"},{"name":"Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Gross","sequence":"additional","affiliation":[{"name":"Scott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel F.","family":"Chamorro","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Naskou","sequence":"additional","affiliation":[{"name":"Scott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, AL"},{"name":"Department of Pathobiology, College of Veterinary Medicine, Auburn University, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aime K.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Scott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, AL"},{"name":"Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenny V.","family":"Brock","sequence":"additional","affiliation":[{"name":"Edward Via College of Osteopathic Medicine, Auburn, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent R.","family":"Van Kampen","sequence":"additional","affiliation":[{"name":"Van Kampen Group, Payson, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney E.","family":"Willoughby","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin and Milwaukee Children\u2019s Hospital, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"issue":"23","key":"ref1","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"524","article-title":"Vital signs: trends in human rabies deaths and exposures\u2014United States, 1938\u20132018","volume":"68","author":"Pieracci EG","year":"2019","unstructured":"Pieracci EG, Pearson CM, Wallace RM,  Vital signs: trends in human rabies deaths and exposures\u2014United States, 1938\u20132018. MMWR Morb Mortal Wkly Rep. 2019;68(23):524\u2013528. doi:10.15585\/mmwr.mm6823e1"},{"issue":"25","key":"ref2","series-title":"Public Health Rep (1896)","first-page":"785","article-title":"Rabies problems and control","volume":"64","author":"Steele JH","year":"1949","unstructured":"Steele JH, Tierkel ES. Rabies problems and control. Public Health Rep (1896). 1949;64(25):785\u2013796.18151801"},{"issue":"12","key":"ref3","series-title":"N Engl J Med","first-page":"1081","article-title":"On the shoulders of giants \u2014 from Jenner\u2019s cowpox to mRNA Covid vaccines","volume":"384","author":"Desmond A","year":"2021","unstructured":"Desmond A, Offit PA. On the shoulders of giants \u2014 from Jenner\u2019s cowpox to mRNA Covid vaccines. N Engl J Med. 2021;384(12):1081\u20131083. doi:10.1056\/NEJMp203433433764709"},{"issue":"4","key":"ref4","series-title":"PLoS Negl Trop Dis","first-page":"e0003709","article-title":"Global Alliance for Rabies Control Partners for Rabies Prevention. Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson K","year":"2015","unstructured":"Hampson K, Coudeville L, Lembo T, ; Global Alliance for Rabies Control Partners for Rabies Prevention. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 2015;9(4):e0003709. doi:10.1371\/journal.pntd.000370925881058"},{"issue":"10","key":"ref5","series-title":"J Am Vet Med Assoc","first-page":"1157","article-title":"Rabies surveillance in the United States during 2020","volume":"260","author":"Ma X","year":"2022","unstructured":"Ma X, Bonaparte S, Toro M,  Rabies surveillance in the United States during 2020. J Am Vet Med Assoc. 2022;260(10):1157\u20131165. doi:10.2460\/javma.22.03.011235522584"},{"key":"ref6","series-title":"CDC","article-title":"Bats","unstructured":"Bats. CDC. Accessed janusary 10, 2022. https:\/\/www.cdc.gov\/rabies\/exposure\/animals\/bats.html"},{"key":"ref7","series-title":"CDC reports increase in human rabies cases linked to bats in the U.S. CDC","unstructured":"CDC reports increase in human rabies cases linked to bats in the U.S. CDC. Accessed January 6, 2022. https:\/\/www.cdc.gov\/media\/releases\/2022\/p0106-human-rabies.html"},{"issue":"12","key":"ref8","series-title":"Emerg Infect Dis","first-page":"2825-2834","article-title":"Animal rabies surveillance, China, 2004\u20132018","volume":"26","author":"Feng Y","year":"2020","unstructured":"Feng Y, Wang Y, Xu W,  Animal rabies surveillance, China, 2004\u20132018. Emerg Infect Dis. 2020;26(12):2825-2834. doi:10.3201\/eid2612.20030333219645"},{"issue":"11","key":"ref9","series-title":"PLoS Negl Trop Dis","first-page":"e839","article-title":"Rabies, still neglected after 125 years of vaccination","volume":"4","author":"Bourhy H","year":"2010","unstructured":"Bourhy H, Dautry-Varsat A, Hotez PJ, Salomon J. Rabies, still neglected after 125 years of vaccination. PLoS Negl Trop Dis. 2010;4(11):e839. doi:10.1371\/journal.pntd.000083921152052"},{"key":"ref10","series-title":"Rabies in India\u2014everything you need to know. November 9, 2019","unstructured":"Rabies in India\u2014everything you need to know. November 9, 2019. Accessed November 9, 2019. https:\/\/www.iasexpress.net\/rabies-in-india\/"},{"issue":"2","key":"ref11","series-title":"J Commun Dis","first-page":"59","article-title":"Rabies epidemiology and control in India: a review","volume":"44","author":"Acharya AS","year":"2012","unstructured":"Acharya AS, Kaur R, Lakra K. Rabies epidemiology and control in India: a review. J Commun Dis. 2012;44(2):59\u201369.25151750"},{"issue":"34","key":"ref12","series-title":"Proc Natl Acad Sci U S A","first-page":"12273","article-title":"Inner workings: 1885, the first rabies vaccine in humans","volume":"111","author":"Rappuoli R","year":"2014","unstructured":"Rappuoli R. Inner workings: 1885, the first rabies vaccine in humans. Proc Natl Acad Sci U S A. 2014;111(34):12273. doi:10.1073\/pnas.141422611125161260"},{"issue":"11","key":"ref13","series-title":"Expert Rev Vaccines","first-page":"1597","article-title":"From brain passage to cell adaptation: the road of human rabies vaccine development","volume":"10","author":"Wu X","year":"2011","unstructured":"Wu X, Smith TG, Rupprecht CE. From brain passage to cell adaptation: the road of human rabies vaccine development. Expert Rev Vaccines. 2011;10(11):1597\u20131608. doi:10.1586\/erv.11.14022043958"},{"issue":"suppl 1","key":"ref14","series-title":"Vaccine","first-page":"A140","article-title":"New human rabies vaccines in the pipeline","volume":"37","author":"Fooks AR","year":"2019","unstructured":"Fooks AR, Banyard AC, Ertl HCJ. New human rabies vaccines in the pipeline. Vaccine. 2019;37(suppl 1):A140\u2013A145. doi:10.1016\/j.vaccine.2018.08.03930153997"},{"key":"ref15","series-title":"Biologicals","first-page":"83","article-title":"Towards rabies elimination in the Asia-Pacific region: from theory to practice","volume":"64","author":"Rupprecht CE","year":"2020","unstructured":"Rupprecht CE, Abela-Ridder B, Abila R,  Towards rabies elimination in the Asia-Pacific region: from theory to practice. Biologicals. 2020;64:83\u201395. doi:10.1016\/j.biologicals.2020.01.00832089431"},{"key":"ref16","series-title":"Front Vet Sci","first-page":"9","article-title":"Elimination of dog-mediated human rabies deaths by 2030: needs assessment and alternatives for progress based on dog vaccination","volume":"4","author":"Wallace RM","year":"2017","unstructured":"Wallace RM, Undurraga EA, Blanton JD, Cleaton J, Franka R. Elimination of dog-mediated human rabies deaths by 2030: needs assessment and alternatives for progress based on dog vaccination. Front Vet Sci. 2017;4:9. doi:10.3389\/fvets.2017.0000928239608"},{"issue":"40","key":"ref17","series-title":"Vaccine","first-page":"4442","article-title":"Concomitant administration of GonaCon and rabies vaccine in female dogs (Canis familiaris) in Mexico","volume":"31","author":"Vargas-Pino F","year":"2013","unstructured":"Vargas-Pino F, Guti\u00e9rrez-Cedillo V, Canales-Vargas EJ,  Concomitant administration of GonaCon and rabies vaccine in female dogs (Canis familiaris) in Mexico. Vaccine. 2013;31(40):4442\u20134447. doi:10.1016\/j.vaccine.2013.06.06123871822"},{"issue":"51","key":"ref18","series-title":"Vaccine","first-page":"7202","article-title":"Development of combined vaccines for rabies and immunocontraception","volume":"27","author":"Wu X","year":"2009","unstructured":"Wu X, Franka R, Svoboda P, Pohl J, Rupprecht CE. Development of combined vaccines for rabies and immunocontraception. Vaccine. 2009;27(51):7202\u20137209. doi:10.1016\/j.vaccine.2009.09.02519925954"},{"issue":"3","key":"ref19","series-title":"Vaccines (Basel)","first-page":"73","article-title":"Inactivated rabies virus-vectored immunocontraceptive vaccine in a thermo-responsive hydrogel induces high and persistent antibodies against rabies, but insufficient antibodies against gonadotropin-releasing hormone for contraception","volume":"7","author":"Wu X","year":"2019","unstructured":"Wu X, Yang Y, Kling C,  Inactivated rabies virus-vectored immunocontraceptive vaccine in a thermo-responsive hydrogel induces high and persistent antibodies against rabies, but insufficient antibodies against gonadotropin-releasing hormone for contraception. Vaccines (Basel). 2019;7(3):73. doi:10.3390\/vaccines7030073"},{"key":"ref20","series-title":"Front Microbiol","first-page":"1070","article-title":"A bivalent human adenovirus type 5 vaccine expressing the rabies virus glycoprotein and canine distemper virus hemagglutinin protein confers protective immunity in mice and foxes","volume":"11","author":"Yan L","year":"2020","unstructured":"Yan L, Zhao Z, Xue X,  A bivalent human adenovirus type 5 vaccine expressing the rabies virus glycoprotein and canine distemper virus hemagglutinin protein confers protective immunity in mice and foxes. Front Microbiol. 2020;11:1070. doi:10.3389\/fmicb.2020.0107032612580"},{"key":"ref21","series-title":"Methods and compositions for viral vectored GnRH vaccines to control reproduction and breeding behavior in mammals","author":"Baker H","year":"2018","unstructured":"Baker H, Zhang J, Van Kampen KR, Roberts S, Tang D-CC, inventors; Auburn University, Altimmne Inc, assignees. Methods and compositions for viral vectored GnRH vaccines to control reproduction and breeding behavior in mammals. US patent WO2018089593A1. May 17, 2018."},{"issue":"RR-3","key":"ref22","series-title":"MMWR Recomm Rep","first-page":"1","article-title":"Human rabies prevention\u2014United States, 2008: recommendations of the Advisory Committee on Immunization Practices","volume":"57","author":"Manning SE","year":"2008","unstructured":"Manning SE, Rupprecht CE, Fishbein D,  Human rabies prevention\u2014United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2008;57(RR-3):1\u201328.18496505"},{"key":"ref23","series-title":"ScientificWorldJournal","first-page":"569712","article-title":"Laboratory diagnosis of human rabies: recent advances","volume":"2013","author":"Mani RS","year":"2013","unstructured":"Mani RS, Madhusudana SN. Laboratory diagnosis of human rabies: recent advances. ScientificWorldJournal. 2013;2013:569712. doi:10.1155\/2013\/56971224348170"},{"issue":"suppl 1","key":"ref24","series-title":"Vaccine","first-page":"A85","article-title":"The WHO position on rabies immunization\u20142018 updates","volume":"37","author":"O\u2019Brien KL","year":"2019","unstructured":"O\u2019Brien KL, Nolan T; SAGE WG on Rabies. The WHO position on rabies immunization\u20142018 updates. Vaccine. 2019;37(suppl 1):A85\u2013A87. doi:10.1016\/j.vaccine.2018.10.01430342901"},{"issue":"33","key":"ref25","series-title":"Vaccine","first-page":"4251","article-title":"Cost effectiveness of rabies post exposure prophylaxis in the United States","volume":"26","author":"Dhankhar P","year":"2008","unstructured":"Dhankhar P, Vaidya SA, Fishbien DB, Meltzer MI. Cost effectiveness of rabies post exposure prophylaxis in the United States. Vaccine. 2008;26(33):4251\u20134255. doi:10.1016\/j.vaccine.2008.05.04818599167"},{"issue":"1","key":"ref26","series-title":"Hum Vaccin Immunother","first-page":"2027714","article-title":"Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis","volume":"18","author":"Wang SY","year":"2022","unstructured":"Wang SY, Sun JF, Liu P,  Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis. Hum Vaccin Immunother. 2022;18(1):2027714. doi:10.1080\/21645515.2022.202771435192787"},{"issue":"suppl 1","key":"ref27","series-title":"Vaccine","first-page":"A6","article-title":"Working group on rabies PEP logistics. Overview of rabies post-exposure prophylaxis access, procurement and distribution in selected countries in Asia and Africa, 2017\u20132018","volume":"37","author":"Sreenivasan N","year":"2019","unstructured":"Sreenivasan N, Li A, Shiferaw M,  Working group on rabies PEP logistics. Overview of rabies post-exposure prophylaxis access, procurement and distribution in selected countries in Asia and Africa, 2017\u20132018. Vaccine. 2019;37(suppl 1):A6\u2013A13. doi:10.1016\/j.vaccine.2019.04.024"},{"issue":"1","key":"ref28","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"31","article-title":"Notes from the field: three human rabies deaths attributed to bat exposures\u2014United States, August 2021","volume":"71","author":"Kunkel A","year":"2022","unstructured":"Kunkel A, Minhaj FS, Whitehill F,  Notes from the field: three human rabies deaths attributed to bat exposures\u2014United States, August 2021. MMWR Morb Mortal Wkly Rep. 2022;71(1):31\u201332. doi:10.15585\/mmwr.mm7101a5"},{"key":"ref29","series-title":"Rabies in the U.S. CDC","unstructured":"Rabies in the U.S. CDC. Accessed April 6, 2020. https:\/\/www.cdc.gov\/rabies\/location\/usa\/index.html"},{"issue":"5","key":"ref30","series-title":"J Am Vet Med Assoc","first-page":"505","article-title":"Compendium of animal rabies prevention and control, 2016","volume":"248","author":"Brown C","year":"2016","unstructured":"Brown C, Slavinski S, Ettestad P, Sidwa TJ, Sorhage FE. Compendium of animal rabies prevention and control, 2016. J Am Vet Med Assoc. 2016;248(5):505\u2013517. doi:10.2460\/javma.248.5.505. Published correction appears in. J Am Vet Med Assoc. 2016;248(7):771. doi:10.2460\/javma.248.7.77126885593"},{"issue":"8","key":"ref31","series-title":"J Gen Virol","first-page":"1171","article-title":"Trying to treat the untreatable: experimental approaches to clear rabies virus infection from the CNS","volume":"100","author":"Smith SP","year":"2019","unstructured":"Smith SP, Wu G, Fooks A, Ma J, Banyard A. Trying to treat the untreatable: experimental approaches to clear rabies virus infection from the CNS. J Gen Virol. 2019;100(8):1171\u20131186. doi:10.1099\/jgv.0.00126931237530"},{"issue":"24","key":"ref32","series-title":"N Engl J Med","first-page":"2508","article-title":"Survival after treatment of rabies with induction of coma","volume":"352","author":"Willoughby RE Jr","year":"2005","unstructured":"Willoughby RE Jr, Tieves KS, Hoffman GM,  Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352(24):2508\u20132514. doi:10.1056\/NEJMoa05038215958806"},{"issue":"suppl 1","key":"ref33","series-title":"Int J Infect Dis","first-page":"438","article-title":"Rabies virus infection: role of the rabies virus phosphoprotein in producing neuronal injury mediated by mitochondrial dysfunction and oxidative stress","volume":"45","author":"Jackson A","year":"2016","unstructured":"Jackson A, Kammouni W, Wood H, Carpenter M. Rabies virus infection: role of the rabies virus phosphoprotein in producing neuronal injury mediated by mitochondrial dysfunction and oxidative stress. Int J Infect Dis. 2016;45(suppl 1):438. doi:10.1016\/j.ijid.2016.02.930"},{"issue":"5","key":"ref34","series-title":"Nat Rev Genet","first-page":"265","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska K","year":"2022","unstructured":"Paunovska K, Loughrey D, Dahlman JE. Drug delivery systems for RNA therapeutics. Nat Rev Genet. 2022;23(5):265\u2013280. doi:10.1038\/s41576-021-00439-434983972"},{"issue":"12","key":"ref35","series-title":"Pharmaceutics","first-page":"2015","article-title":"Antisense oligonucleotide-based therapy of viral infections","volume":"13","author":"Tarn W-Y","year":"2021","unstructured":"Tarn W-Y, Cheng Y, Ko S-H, Huang L-M. Antisense oligonucleotide-based therapy of viral infections. Pharmaceutics. 2021;13(12):2015. doi:10.3390\/pharmaceutics1312201534959297"},{"issue":"1","key":"ref36","series-title":"Virus Res","first-page":"169","article-title":"Small interfering RNAs targeting the rabies virus nucleoprotein gene","volume":"169","author":"Yang Y-J","year":"2012","unstructured":"Yang Y-J, Zhao P-S, Zhang T,  Small interfering RNAs targeting the rabies virus nucleoprotein gene. Virus Res. 2012;169(1):169\u2013174. doi:10.1016\/j.virusres.2012.07.02422884777"},{"issue":"4","key":"ref37","series-title":"J Cell Biol","first-page":"559","article-title":"A Nobel Prize for membrane traffic: vesicles find their journey\u2019s end","volume":"203","author":"Mellman I","year":"2013","unstructured":"Mellman I, Emr SD. A Nobel Prize for membrane traffic: vesicles find their journey\u2019s end. J Cell Biol. 2013;203(4):559\u2013561. doi:10.1083\/jcb.20131013424215073"},{"issue":"4","key":"ref38","series-title":"Nat Biotechnol","first-page":"341","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti L","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341\u2013345. doi:10.1038\/nbt.1807"},{"key":"ref39","series-title":"Front Neurosci","first-page":"163","article-title":"Therapeutic potential of extracellular vesicles for the treatment of nerve disorders","volume":"13","author":"Galieva LR","year":"2019","unstructured":"Galieva LR, James V, Mukhamedshina YO, Rizvanov AA. Therapeutic potential of extracellular vesicles for the treatment of nerve disorders. Front Neurosci. 2019;13:163. doi:10.3389\/fnins.2019.0016330890911"},{"key":"ref40","series-title":"Antibody gene therapy for treatment and prevention of infection by rabies lyssavirus","article-title":"Auburn University","author":"Baker HMD","year":"2021","unstructured":"Baker HMD, Van Kampen KR, Esteves MS, inventors; Auburn University, assignee. Antibody gene therapy for treatment and prevention of infection by rabies lyssavirus. US patent application PCT\/US2020\/051284. March 25, 2021."},{"key":"ref41","article-title":"Antibody gene therapy for rabies encephalitis","author":"Baker HJ","unstructured":"Baker HJ, Van Kampen KR, Panayampalli S,  Antibody gene therapy for rabies encephalitis. Abstract presented at: 32 RITA Brasil; October 28, 2021; online."},{"key":"ref42","article-title":"First-in-human use of favipiravir plus AAV-RAB for rabies encephalitis","author":"Walczyszyn M","unstructured":"Walczyszyn M, Cervellione K, Patel H,  First-in-human use of favipiravir plus AAV-RAB for rabies encephalitis. Abstract presented at: 32 RITA Brasil; October 28, 2021; online."},{"issue":"10","key":"ref43","series-title":"Proc Natl Acad Sci U S A","first-page":"E861","article-title":"Host-rabies virus protein-protein interactions as druggable antiviral targets","volume":"110","author":"Lingappa UF","year":"2013","unstructured":"Lingappa UF, Wu X, Macieik A,  Host-rabies virus protein-protein interactions as druggable antiviral targets. Proc Natl Acad Sci U S A. 2013;110(10):E861\u2013E868. doi:10.1073\/pnas.121019811023404707"},{"issue":"4","key":"ref44","series-title":"Trends Pharmacol Sci","first-page":"281","article-title":"Axons matter: the promise of treating neurodegenerative disorders by targeting SARM1-mediated axonal degeneration","volume":"41","author":"Krauss R","year":"2020","unstructured":"Krauss R, Bosanac T, Devraj R, Engber T, Hughes RO. Axons matter: the promise of treating neurodegenerative disorders by targeting SARM1-mediated axonal degeneration. Trends Pharmacol Sci. 2020;41(4):281\u2013293. doi:10.1016\/j.tips.2020.01.00632107050"}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/261\/4\/javma.22.09.0420.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/261\/4\/javma.22.09.0420.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/261\/4\/javma.22.09.0420.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T22:02:25Z","timestamp":1727301745000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/261\/4\/javma.22.09.0420.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":44,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.2460\/javma.22.09.0420","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,1]]}}}